Although other study groups did not offer a stratified analysis, they also contributed to the idea of a poor prognostic impact of CD13 expression in NSCLC [15,16] (S1 Table) as well as in other tumor types such as pancreatic carcinoma [28], ovarian cancer [18] and colon carcinoma [9]. This evidence concerns the gene ANPEP and ovarian cancer.